Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Home/IPO/Paras Healthcare IPO
Updated: 19-Oct 10:37
Paras Healthcare

Paras Healthcare IPO

UpcomingIPO

Listing at: BSE, NSE • 1 st Floor, Tower B,Paras Twin Towers,Golf Course Road, Sector 54,Gurugram, Haryana, 122002

Allotment status Declaration not confirmed

Disclaimer: GMP values change dynamically. This data is strictly for educational purposes only and not an investment advice.

Live GMP Today
₹92 (13.28%)
Rating:3/5
Est. Listing Price
₹785
Est. Gain: +13.3%
Est. Profit / Lot
₹1,932
Per Retail Application
Price Band
₹693
Face Value: ₹1
Min. Retail Inv.
₹14,553
Lot: 21 Shares
Total Subscription
-
Anchor: Yes

Paras Healthcare IPO GMP History

Genuine daily snapshots retained by the WeeStox backend

Disclaimer: GMP values change dynamically. This data is strictly for educational purposes only and not an investment advice.

GMP dateIPO priceGMPPremiumEst. profit / lotSubscriptionMovement
19 Oct 2026₹693+₹9213.28%+₹1,932-Flat
18 Oct 2026₹693+₹9213.28%+₹1,932-↓ Down
17 Oct 2026₹693+₹9613.85%+₹2,016-↑ Up
16 Oct 2026₹693+₹9513.71%+₹1,995-↑ Up
15 Oct 2026₹693+₹8512.27%+₹1,785-↑ Up
14 Oct 2026₹693+₹830.00%+₹1,743-Flat

Explore the complete GMP movement

Open the chart and all available daily records.

Paras Healthcare IPO Details

IPO Date21 Oct 2026 to 23 Oct 2026
Listing AtBSE, NSE
Face Value₹1 per share
Price Band₹693
Lot Size21 Shares
Total Issue Size₹1450.00 Cr(₹1,255.57 Cr)
Fresh Issue72.15L shares (₹500 Cr)
Offer for Sale (OFS)₹950 Cr (approx 2.74 Cr shares)
Issue TypeBook Built Issue IPO

Paras Healthcare IPO Timetable

IPO Open Date21 Oct 2026
IPO Close Date23 Oct 2026
Basis of Allotment26 Oct 2026
Initiation of Refunds27 Oct 2026
Credit of Shares to Demat27 Oct 2026
Listing Date28 Oct 2026
Cut-off time for UPI Mandate5 PM on 23 Oct 2026
Employee Discount₹20.00/share (Up to 52,083 shares)

Paras Healthcare IPO Reservation

CategoryReservationShares Offered
QIB Shares Offered75.00%1,56,92,640
HNI Shares Offered15.00%31,38,528
Retail Shares Offered10.00%20,92,352
Total Shares Offered100.00%2,09,23,520

Paras Healthcare Anchor Details

Anchor investor bidding data has not been announced or is not applicable.

Paras Healthcare IPO Lot Size

ApplicationLotsSharesAmount (Cut-off)Reserved Applications
Retail (Min)1 Lot Shares₹14,553–
Retail (Max)13 Lots Shares₹1,89,189–
S-HNI (Min)14 Lots Shares₹2,03,742–
S-HNI (Max)68 Lots Shares₹9,89,604–
B-HNI (Min)69 Lots Shares₹10,04,157–

Paras Healthcare Promoter Holding

Pre-Issue HoldingDisclosed in RHP
Post-Issue HoldingTo be calculated

Paras Healthcare IPO Live Subscription Status

Bidding demand breakdown by shares, institutional demand in ₹ Cr, applications & HNI funding cost
Overall Demand:-
03:30 am
Investor CategoryShares OfferedShares BiddedSubscription Times

Paras Healthcare Limited Financial Information (Restated Consolidated in ₹ Crores)

Period EndedAssetsTotal IncomeProfit After TaxEBITDANet WorthTotal Borrowing
30 Jun 2026₹2202.88 Cr₹478.75 Cr₹49.68 Cr₹113.48 Cr₹444.96 Cr₹1429.49 Cr
31 Mar 2026₹2071.14 Cr₹1628.78 Cr₹43.83 Cr₹335.58 Cr₹394.94 Cr₹1393.86 Cr
31 Mar 2025₹1810.45 Cr₹1314.21 Cr₹-57.98 Cr₹156.46 Cr₹280.49 Cr₹1232.12 Cr
31 Mar 2024₹1477.66 Cr₹1151.02 Cr₹-15.33 Cr₹154.41 Cr₹338.51 Cr₹923.92 Cr

Paras Healthcare Key Valuation & Financial KPIs

ROE11.83%
ROCE4.23%
Debt / Equity3.21x
P/E (Post IPO)37.72
EBITDA Margin23.70%
Market Cap₹7498.3 Cr

Paras Healthcare IPO Analysis

Review the company's key advantages and material business risks.

8 Strengths

Strengths & Positives

Competitive advantages and operational merits

  • Paras Healthcare Limited was incorporated in 1987 and operates a network of eight hospitals with an aggregate bed capacity of 2,211 beds as of June 30, 2026, across five states and one union territory in North India, Bihar and Jharkhand under the 'Paras Health' brand.

  • The company is a clinical specialty-led hospital platform focused on tertiary and quaternary care, with deep capabilities across cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and renal sciences (collectively, CONGOR), which together contributed over 70% of revenue from operations in recent periods.

  • Largest Healthcare Provider with First-Mover Advantage: The company is one of the largest healthcare providers in North India, Bihar and Jharkhand by bed capacity, with 2,211 beds across eight hospitals as of June 30, 2026, several of which were first corporate hospital entrants in their respective markets.

  • Strong Focus on Tertiary and Quaternary Care: CONGOR specialties, comprising cardiac, oncology, neuro, gastro, orthopedics and renal sciences, accounted for 74.70%, 71.92% and 72.34% of revenue from operations in Fiscals 2026, 2025 and 2024, respectively, supported by dedicated ICU infrastructure and transplant programs.

  • Capital-Efficient and Flexible Operating Model: The company operates hospitals through a mix of owned, leased, revenue-share and public-private partnership structures, enabling disciplined, capital-efficient expansion with a capital expenditure per bed of ₹7.70 million as of June 30, 2026.

  • History of Losses: The company incurred consolidated losses of ₹(10.24) million, ₹(579.83) million and ₹(153.31) million in the three months ended June 30, 2025 and Fiscals 2025 and 2024, respectively, and there is no assurance that profitability achieved in Fiscal 2026 will continue.

  • Subsidiary Losses: Subsidiaries PHRPL and PMHPL together incurred losses of ₹(203.82) million, ₹(520.89) million, ₹(822.38) million and ₹(872.69) million in the three months ended June 30, 2025 and Fiscals 2026, 2025 and 2024, as their hospitals continue to scale up operations.

  • High Attrition Among Healthcare Staff: The company experienced attrition rates of 12.01%, 16.09%, 60.38%, 66.74% and 65.27% among doctors, nurses and other staff in the relevant periods, and failure to manage attrition could adversely affect service quality and operations.

About Paras Healthcare Limited

Paras Healthcare IPO is a book build issue of ₹1,450.00 crores. The issue is a combination of fresh issue of 72.15 lakh shares aggregating to ₹500.00 crores and offer for sale of 1.37 crore shares aggregating to ₹950.00 crores.Paras Healthcare IPO opens for subscription on Oct 21, 2026 and closes on Oct 23, 2026. The allotment for the Paras Healthcare IPO is expected to be finalized on Oct 26, 2026. Paras Healthcare IPO will list on NSE and BSE with a tentative listing date fixed as Oct 28, 2026.Paras Healthcare IPO is set issue price band at ₹660 to ₹693 per share. The lot size for an application is 21 shares. The minimum amount of investment required by an individual investor (retail) is ₹14,553 (21 shares) (based on upper price).JM Financial Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.Refer to Paras Healthcare IPO RHP for detailed Information.

Incorporated in1987, Paras Healthcare Limited is a leading clinical specialty-led hospital platform providing tertiary and quaternary healthcare services across North India, Bihar, and Jharkhand under the "Paras Health" brand. The company operates eight hospitals with an aggregate bed capacity of 2,211 beds across Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi, and Srinagar as of June 30, 2026. It specializes in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics & sports injury, and renal sciences (CONGOR specialties), which contributed 75.30% of revenue in Fiscal 2026. Paras Healthcare has over 20 years of operating history and follows a balanced growth strategy through mature, emerging, and new hospitals. The company plans to expand its network with a 300-bed hospital in Gurugram and a 500-bed hospital in Ludhiana, increasing total capacity to 3,011 beds by March 2028. As of March 31, 2026, it had 4,670 employees, including 1,084 doctors and 1,937 nurses. • Leading healthcare provider in North India, Bihar, and Jharkhand. • Network of 8 hospitals with 2,211-bed capacity. • Strong Paras Health brand with over 20 years of experience. • Focus on high-acuity CONGOR specialties. • Balanced portfolio of mature, emerging, and new hospitals. • Strong occupancy growth and operational efficiency. • Experienced workforce of 1,011 doctors and 1,665 nurses. • Expansion pipeline to reach 3,011 beds by FY28. • Advanced clinical infrastructure and standardized care protocols.

Shariah Compliance Screening (AAOIFI Standard 21)

Business ActivityRequires ReviewImpermissible Revenue ≤ 5%
Debt-to-Assets Ratio64.89%Threshold ≤ 33% of Assets
Purification GuidanceStandard 0.5%Donate interest dividend fraction
Auditor Notes: Core business operations align with Shariah permissible activities.

Paras Healthcare IPO Documents & Reports

Official prospectus, reports and regulatory filings
Document TitleAuthority / HostStatusAction
Red Herring Prospectus (RHP)
Complete offer document filed with ROC & SEBI
SEBI / ROCAvailablePending
Draft Red Herring Prospectus (DRHP)
Initial regulatory draft submitted for public comments
SEBI FilingsFiled View DRHP
Anchor Investor Allocation Report
Allotment list to institutional bidders
BSE / NSE CircularN/ANot Applicable
IPO Allotment Status & Basis of Allotment
Registrar query portal via PAN / Application No.
MUFG Intime India Pvt.Ltd.Live Portal Check Allotment
Corporate Website & Investor Relations
Official portal and financial reports
Issuer PortalActive Visit Portal

Paras Healthcare IPO Registrar & Lead Managers

Registrar of the Issue
MUFG Intime India Pvt.Ltd.
022-49186000
Book Running Lead Managers (BRLM)
  • JM Financial Ltd.
  • BOFA Securities India Ltd.
  • Nuvama Wealth Management Ltd.
Registered Office

1 st Floor, Tower B,Paras Twin Towers,Golf Course Road, Sector 54,Gurugram, Haryana, 122002

Paras Healthcare IPO FAQs

What is IPO GMP, and does it guarantee a listing gain?

Grey market premium is an unofficial price indication outside the exchange. It can change quickly and does not guarantee the exchange listing price, liquidity or a profit. Read it alongside the prospectus, valuation, financials and risks.

How do I check Paras Healthcare IPO allotment status?

Open the individual IPO report and check its allotment update and registrar details. Confirm your application outcome through the official registrar or exchange service. A scheduled allotment date is not confirmation that allotment has been declared.

What does IPO subscription mean?

Subscription compares shares bid for with shares offered in a category. For example, 2 times subscription means bids for twice the available shares in that category. Retail, institutional and other categories can have different demand; subscription alone does not establish investment quality.

How is an indicative IPO listing price calculated from GMP?

A commonly used illustration adds reported GMP to the issue price, or upper price band before the final price is known. It is a sentiment illustration, not an exchange quote or reliable forecast. Missing GMP should not be interpreted as zero.

Where can I find IPO dates, price bands and lot sizes?

The individual IPO report brings together available issue dates, price bands, lot sizes, subscription and company details. Check the final prospectus and exchange announcements before applying because issue terms can change.